FOLLOW US

  • facebook
  • twitter
Mon

March 9, 2026

Novo Nordisk $2.1 billion licensing deal

America October 15, 2025

Novo Nordisk Inks $2.1B Licensing Deal for Rare Disease Breakthrough

In a bold move to deepen its footprint in rare disease treatment, Novo Nordisk SA announced Wednesday that it will…

By Rihem Akkouche

BioCryst to acquire Astria

America October 14, 2025

BioCryst to Acquire Astria in $700M Deal

In a bold move that strengthens its foothold in the rare disease and immunology market, BioCryst Pharmaceuticals Inc. announced Tuesday…

By Rihem Akkouche

AstraZeneca acquires Amolyt in $1B deal

America March 14, 2024

AstraZeneca acquires Amolyt in $1B deal

AstraZeneca, a pharmaceutical giant, announced on Thursday its acquisition of Amolyt Pharma, a clinical stage biotechnology company, in a deal…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter